Change in Trajectories of Adherence to Lipid-Lowering Drugs Following Non-Fatal Acute Coronary Syndrome or Stroke.
Ontology highlight
ABSTRACT: Background Poor adherence to cardioprotective drugs remains a concern among patients for secondary prevention. A better understanding of adherence fluctuations before and after critical health events may inform approaches for addressing or preventing poor adherence. Therefore, we assessed trajectories of adherence to lipid-lowering drugs before and after acute coronary syndrome (ACS) or stroke and identified post-ACS/stroke trajectories' predictors. Methods and Results We conducted a cohort study of patients hospitalized for ACS or stroke in Alberta, Canada, using administrative health data between 2009 and 2015. Patients using lipid-lowering drugs in the 2 years pre-hospitalization and had post-discharge follow-up ≥365 days were included. We used group-based trajectory modeling to assess
SUBMITTER: Zongo A
PROVIDER: S-EPMC6912969 | biostudies-literature | 2019 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA